(Q48952718)

English

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study

scientific article published in April 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

J Versijpt

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

J C Debruyne

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

K J Van Laere

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

F De Vos

4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

J Keppens

5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

K Strijckmans

6

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

E Achten

7

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

G Slegers

8

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

R A Dierckx

9

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

J Korf

10

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

J L De Reuck

11

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

11

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

127-134

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Indictment of the microglia as the villain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Molecular mechanisms of axonal damage in inflammatory central nervous system diseases

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

PET visualization of microglia in multiple sclerosis patients using [11C]PK11195

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

MRI techniques to monitor MS evolution: the present and the future

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Comparing functional (PET) images: the assessment of significant change

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

A JAVA environment for medical image data analysis: initial application for brain PET quantitation

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Multimodal image coregistration and partitioning--a unified framework

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Myelination in the absence of myelin-associated glycoprotein

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

MRI in the diagnosis and management of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Optimizing the association between disability and biological markers in MS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Prenatal diazepam induced persisting downregulation of peripheral (omega 3) benzodiazepine receptors on rat splenic macrophages.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Multiple sclerosis: a white matter disease with associated gray matter damage

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1140OA

21 January 2018

Identifiers

10.1191/1352458505MS1140OA

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/15794383

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48952718&oldid=2236453434"